MARZOLA, Erika
 Distribuzione geografica
Continente #
NA - Nord America 4.167
AS - Asia 1.868
EU - Europa 1.482
SA - Sud America 302
AF - Africa 41
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.866
Nazione #
US - Stati Uniti d'America 4.081
SG - Singapore 806
CN - Cina 536
IT - Italia 390
DE - Germania 252
BR - Brasile 236
HK - Hong Kong 171
UA - Ucraina 158
PL - Polonia 157
GB - Regno Unito 154
TR - Turchia 106
FI - Finlandia 101
VN - Vietnam 98
SE - Svezia 58
CA - Canada 52
RU - Federazione Russa 51
FR - Francia 45
ID - Indonesia 42
MX - Messico 28
BE - Belgio 27
AR - Argentina 26
ZA - Sudafrica 26
NL - Olanda 24
JP - Giappone 22
IN - India 21
CO - Colombia 16
LT - Lituania 14
BD - Bangladesh 12
IE - Irlanda 11
AT - Austria 10
ES - Italia 10
IR - Iran 10
EC - Ecuador 7
IQ - Iraq 7
IL - Israele 6
PK - Pakistan 6
UY - Uruguay 6
CZ - Repubblica Ceca 5
PE - Perù 4
RO - Romania 4
SA - Arabia Saudita 4
BG - Bulgaria 3
KZ - Kazakistan 3
PY - Paraguay 3
TN - Tunisia 3
UZ - Uzbekistan 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AL - Albania 2
AO - Angola 2
AU - Australia 2
DZ - Algeria 2
KE - Kenya 2
KR - Corea 2
MA - Marocco 2
MY - Malesia 2
PA - Panama 2
PT - Portogallo 2
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
CV - Capo Verde 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GE - Georgia 1
HU - Ungheria 1
JO - Giordania 1
LV - Lettonia 1
MU - Mauritius 1
NI - Nicaragua 1
NP - Nepal 1
NR - Nauru 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 7.866
Città #
Ashburn 483
Singapore 465
Fairfield 423
Woodbridge 404
Ann Arbor 238
Houston 219
Beijing 213
Santa Clara 192
Seattle 186
Hong Kong 168
Jacksonville 168
Chandler 166
Ferrara 161
Warsaw 152
Cambridge 149
Wilmington 147
New York 102
Munich 89
Dallas 73
Los Angeles 73
Milan 63
Izmir 59
Princeton 52
Dearborn 47
Nanjing 47
Addison 44
Helsinki 39
Shanghai 39
Ho Chi Minh City 38
San Diego 36
Jakarta 33
Turku 31
Boardman 30
Brussels 25
London 24
São Paulo 24
Bologna 23
Tokyo 21
Falkenstein 19
Montreal 19
Frankfurt am Main 18
Mexico City 18
Atlanta 17
Auburn Hills 16
Brooklyn 16
Chicago 16
Johannesburg 16
Redwood City 16
Hefei 15
Nanchang 15
Toronto 14
The Dalles 13
Bremen 12
Buffalo 12
San Mateo 12
Boston 11
Ferrara di Monte Baldo 11
Hanoi 11
San Francisco 11
Shenyang 11
Changsha 10
Denver 10
Dublin 10
Hebei 10
Mountain View 10
Phoenix 10
Tianjin 10
Manchester 9
Medellín 9
Moscow 9
Padova 9
Turin 9
Istanbul 8
Jinan 8
Norwalk 8
Philadelphia 8
Stockholm 8
Washington 8
Augusta 7
Bexley 7
Columbus 7
Jiaxing 7
Ningbo 7
Poplar 7
Tappahannock 7
Curitiba 6
Florence 6
Guangzhou 6
Montevideo 6
Nuremberg 6
Orem 6
Zhengzhou 6
Biên Hòa 5
Charlotte 5
Chennai 5
Dong Ket 5
Falls Church 5
Kunming 5
Lima 5
Rio de Janeiro 5
Totale 5.559
Nome #
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 246
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 238
Involvement of cell surface TG2 in the aggregation of K562 cells triggered by gluten 237
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 214
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 204
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 203
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 201
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 196
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH2 195
Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors 194
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 193
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 190
Physicochemical stability of cabazitaxel and docetaxel solutions 186
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 185
Pharmacological characterization of tachykinin tetrabranched derivatives 185
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 184
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 175
Disordered Peptides Looking for Their Native Environment: Structural Basis of CB1 Endocannabinoid Receptor Binding to Pepcans 167
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with C alpha,alpha-dialkylated amino acids 166
Structure-activity study at positions 3 and 4 of human neuropeptide S. 164
Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies 162
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 161
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 158
Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors 153
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 153
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): Identification of a partial agonist of the UT receptor 150
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors 150
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 148
Structure-activity relationship study on human urotensin II 146
Synthesis and antimicrobial activity of dermaseptin S1 analogues 144
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen(5), DTrp(7), Dab(8)] urotensin II(4-11) (UFP-803) 143
Structure-activity studies on neuropeptide S - Identification of the amino acid residues crucial for receptor activation 139
Thermodynamic and spectroscopic investigation on the role of Met residues in CuII binding to the non-octarepeat site of the human prion protein 139
ANALOGHI DERMASEPTINICI AD ATTIVITA’ ANTIMICROBICA 136
Synthesis of 2,6-Dimethyltyrosine-Like Amino Acids through Pinacolinamide-Enabled C-H Dimethylation of 4-Dibenzylamino Phenylalanine 130
Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects 128
Role of 2′,6′-dimethyl-l-tyrosine (Dmt) in some opioid lead compounds 125
Structure-Activity Relationship Studies on Oxazolo[3,4- a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent in Vivo Activity 123
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands 115
Novel Mixed NOP/Opioid Receptor Peptide Agonists 114
How terminal protection affects the chemical and biological properties of the antimicrobial calcitermin 112
Impact of C- and N-terminal protection on the stability, metal chelation and antimicrobial properties of calcitermin 101
Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines 99
CCR4+ CD8+ T cells clonally expand to differentiated effectors in murine psoriasis and in human psoriatic arthritis 94
null 94
The N-terminal domain of Helicobacter pylori's Hpn protein: The role of multiple histidine residues 85
Manganese complexes for multimodal PET/MRI imaging: progress of METRICS project 83
METRICS project: Synthesis of Manganese Complexes as potential PET/MRI Agents 83
A Multi-Angle Approach to Predict Peptide-GPCR Complexes: The N/OFQ-NOP System as a Successful AlphaFold Application Case Study 82
Synthesis and characterization of manganese dithiocarbamate complexes: New evidence of dioxygen activation 78
In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays 70
Positively charged residues play a significant role in enhancing the antibacterial activity of calcitermin 66
Racemic synthesis and solid phase peptide synthesis application of the chimeric valine/leucine derivative 2-amino-3,3,4-trimethyl-pentanoic acid 63
Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity 53
null 42
Production and Characterization of Semi-Solid Formulations for the Delivery of the Cosmetic Peptide Palmitoyl-GHK 40
Synthesis and Pharmacological Characterization of Nociceptin/Orphanin FQ Dimeric Ligands 14
Totale 7.999
Categoria #
all - tutte 39.145
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 515
Totale 39.660


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021472 0 0 0 0 0 67 79 83 36 71 95 41
2021/2022595 28 53 47 42 33 14 35 37 37 51 55 163
2022/2023485 58 31 26 54 62 50 55 50 46 2 29 22
2023/2024396 31 41 26 10 16 90 17 46 10 11 18 80
2024/20251.453 35 29 146 62 175 142 28 71 255 129 188 193
2025/20262.124 460 158 329 481 624 72 0 0 0 0 0 0
Totale 7.999